Vicky Pathare ...

The efforts of CNIC and CMIE are setting the stage for this future, ensuring that Canada remains at the cutting edge of ...

An AI approach developed by researchers from the University of Sheffield and AstraZeneca, could make it easier to design ...

AstraZeneca PLC closed 19.20% below its 52-week high of £133.88, which the company achieved on September 3rd.

Scientists have developed a new machine learning framework that has shown the potential to be more accurate at inverse ...

Now that Ultomiris has matched the indications of its predecessor Soliris, AstraZeneca is eyeing new avenues for the C5 drug ...

Day One officially began on Monday, June 15, 2025, with an automation session chaired by LCGC International’s Pharmaceutical Perspectives columnist, and active member of ChromSoc, Adrian Clarke from ...

Demand is rising for AI-powered robots that can clean offices or roll around moving items from one part of a building to ...

During a live event, Hari Deshpande, MD, and participants discussed the DeFi trial and the management of nirogacestat in ...

Trump's NIH cuts are gutting university labs that fuel Big Pharma's drug pipeline and pushing U.S. biotech jobs, research, ...

AstraZeneca is making a bold move. The drug giant just teamed up with CSPC in a deal worth up to $5.3 billion. The goal? To ...

"We are honored to welcome Dr. Ekuta to our Life Sciences Strategic Advisory Board," said Girish Pashilkar, CEO of BP Logix. ...